In a research report published Friday, Cantor analyst Irina Rivkind maintained a Hold rating on Endo Health Solutions (NASDAQ:ENDP) with a price target of …
In a research report issued today, Cantor analyst Irina Rivkind assigned a Hold rating on Jazz Pharmaceuticals (NASDAQ:JAZZ) and raised her price target to …
Cantor analyst Irina Rivkind maintained a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) but reduced her price target to $8 (from $11), which represents a potential …
In a research report issued today, Cantor analyst Irina Rivkind maintained a Hold rating on Apricus Biosciences (NASDAQ:APRI) and reduces her price target to $1.50 …
In a research report sent to investors today, Cantor analyst Irina Rivkind reiterated a Hold rating on Ligand Pharmaceuticals (NASDAQ:LGND) and reduced her share price target to $43 …
In a research note issued to investors today, Cantor analyst Irina Rivkind assigned a Buy rating on Sucampo (NASDAQ:SCMP) and raised her price target to $14 …
In a research report issued today, Cantor analyst Irina Rivkind maintained a Hold rating on Cubist Pharmaceuticals (NASDAQ:CBST) with a $64 price target, despite strong …
In a research report issued Tuesday, Cantor analyst Irina Rivkind maintained a Buy rating on Valeant Pharmaceuticals (NYSE:VRX) and raised his price target to $182 …
In a research report released Tuesday, analyst Irina Rivkind of Cantor assigned a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with an $11 price target, following the presentation of results …
In a research report issued today, Cantor analyst Irina Rivkind Koffler reiterated a Hold rating on Cubist Pharmaceuticals (NASDAQ:CBST) with a price target …
